Link-J organises “Advanced Therapy Showcase in Tokyo #2 (ATST#2)”

The second Advanced Therapy Showcase in Tokyo is seeking Advanced therapy companies for live-streaming presentations and pre-arranged one-on-one business meetings
Fuelled by the successful rendering of its first edition, ATST#1, in January 2021, Life Science Innovation Network Japan (LINK-J) is organising the second edition of the Advanced Therapy Showcase in Tokyo #2 (ATST#2), on Friday, 28 January 2022, JST.
The Network is currently recruiting live-streaming company presenters, and the recruitment of general attendees will follow soon from November.
The same as its first edition, the ATST#2 focuses on product and technology platform developers in the field of advanced therapy including, but not limited to, regenerative medicine, cell and gene therapy (CGT), nucleic acid therapy, and extracellular vesicles.
This international event is going to be a lively interaction platform for partner seekers at both ends, i.e., seed possessors (start-ups, SMEs, etc.) as presenters, and seed searchers (established pharma companies, corporates, investors, and other relating entities) typically as general audiences.

Date: Friday, 28 January 28, 2022 (JST) held in Combination with “The 6th Industry Academic Government Symposium on Regenerative Medicine”
Venue: Virtual (Tokyo, Japan as its hub)
Field of interest: Advanced therapy including, but not limited to, regenerative medicine, cell and gene therapy (CGT), nucleic acid therapy, and extracellular vesicles
Features: Live-streaming company presentations and pre-arranged one-on-one business meetings
Registration deadlines:
Live-streaming presenters: Friday, 10 December 2021
General attendees: Friday, 28 January 2022 (before the event opens)
Official language: English
Organiser/Sponsor: LINK-J
Registration

Published: October 2021